Emanuel Bahn1, Julia Bauer2, Semi Harrabi2, Klaus Herfarth2, Jürgen Debus3, Markus Alber2. 1. Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: em.bahn@gmail.com. 2. Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany. 3. Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), partner site Heidelberg, Germany.
Abstract
PURPOSE: Late radiation-induced contrast-enhancing brain lesions (CEBLs) on magnetic resonance imaging (MRI) after proton therapy of brain tumors have been observed to occur frequently in regions of high linear energy transfer (LET) and in proximity to the ventricular system. We analyzed 110 patients with low-grade glioma treated with proton therapy to determine whether the risk for CEBLs is increased in proximity to the ventricular system and if there is a relationship between relative biological effectiveness (RBE) and LET. METHODS AND MATERIALS: We contoured CEBLs identified on follow-up T1-MRI scans and computed dose and dose-averaged LET (LETd) distributions for all patients using the Monte Carlo method. We then performed cross-validated voxel-level logistic regression to predict local risks for image change and to extract model parameters, such as the RBE. From the voxel-level model, we derived a model for patient-level risk prediction based on the treatment plan. RESULTS: Of 110 patients, 23 exhibited 1 or several CEBLs on follow-up MRI scans. The voxel-level logistic model has an accuracy as follows: area under the curve of 0.94 and Brier score of 2.6 × 10-5. Model predictions are a 3-fold increased risk in the 4 mm region around the ventricular system and an LETd-dependent RBE of, for example, 1.20 for LETd = 2 keV/μm and 1.50 for LETd = 5 keV/μm. The patient-level risk model has an accuracy as follows: area under the curve of 0.78 and Brier score of 0.13. CONCLUSIONS: Our findings present clinical evidence for an increased risk in ventricular proximity and for a proton RBE that increases significantly with increasing LET. We present a voxel-level model that accurately predicts the localization of late MRI contrast change and extrapolate a patient-level model that allows treatment plan-based risk prediction.
PURPOSE: Late radiation-induced contrast-enhancing brain lesions (CEBLs) on magnetic resonance imaging (MRI) after proton therapy of brain tumors have been observed to occur frequently in regions of high linear energy transfer (LET) and in proximity to the ventricular system. We analyzed 110 patients with low-grade glioma treated with proton therapy to determine whether the risk for CEBLs is increased in proximity to the ventricular system and if there is a relationship between relative biological effectiveness (RBE) and LET. METHODS AND MATERIALS: We contoured CEBLs identified on follow-up T1-MRI scans and computed dose and dose-averaged LET (LETd) distributions for all patients using the Monte Carlo method. We then performed cross-validated voxel-level logistic regression to predict local risks for image change and to extract model parameters, such as the RBE. From the voxel-level model, we derived a model for patient-level risk prediction based on the treatment plan. RESULTS: Of 110 patients, 23 exhibited 1 or several CEBLs on follow-up MRI scans. The voxel-level logistic model has an accuracy as follows: area under the curve of 0.94 and Brier score of 2.6 × 10-5. Model predictions are a 3-fold increased risk in the 4 mm region around the ventricular system and an LETd-dependent RBE of, for example, 1.20 for LETd = 2 keV/μm and 1.50 for LETd = 5 keV/μm. The patient-level risk model has an accuracy as follows: area under the curve of 0.78 and Brier score of 0.13. CONCLUSIONS: Our findings present clinical evidence for an increased risk in ventricular proximity and for a proton RBE that increases significantly with increasing LET. We present a voxel-level model that accurately predicts the localization of late MRI contrast change and extrapolate a patient-level model that allows treatment plan-based risk prediction.
Authors: Jiheon Song; Saif Aljabab; Lulwah Abduljabbar; Yolanda D Tseng; Jason K Rockhill; James R Fink; Lynn Chang; Lia M Halasz Journal: J Neurooncol Date: 2021-04-22 Impact factor: 4.130
Authors: Lars Fredrik Fjæra; Daniel J Indelicato; Kristian S Ytre-Hauge; Ludvig P Muren; Yasmin Lassen-Ramshad; Laura Toussaint; Olav Dahl; Camilla H Stokkevåg Journal: Adv Radiat Oncol Date: 2020-08-28
Authors: Camilla S Byskov; Christian R Hansen; Rikke H Dahlrot; Lene Haldbo-Classen; Charlotte A Haslund; Flemming Kjær-Kristoffersen; Thomas O Kristensen; Yasmin Lassen-Ramshad; Slávka Lukacova; Aida Muhic; Petra W Nyström; Britta Weber; Jesper F Kallehauge Journal: Phys Imaging Radiat Oncol Date: 2021-11-28
Authors: Helge Henjum; Tordis J Dahle; Lars Fredrik Fjæra; Eivind Rørvik; Sara Pilskog; Camilla H Stokkevåg; Andrea Mairani; Kristian S Ytre-Hauge Journal: Adv Radiat Oncol Date: 2021-08-17
Authors: Stewart Mein; Benedikt Kopp; Anthony Vela; Pauline Dutheil; Paul Lesueur; Dinu Stefan; Jürgen Debus; Thomas Haberer; Amir Abdollahi; Andrea Mairani; Thomas Tessonnier Journal: Radiat Oncol Date: 2022-02-04 Impact factor: 3.481